Posttreatment interleukin‐2 in patients with acute myeloid leukemia: The end of a long road for patients and clinical trials?

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|7|940-941

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.7, 2014-04, pp. : 940-941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 138, Iss. 1, 2017-06 ,pp. : 10-13

Karger

Access to resources Recommend Favorite

Recombinant interleukin‐2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 1010-1017

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic Mutations in Patients with Acute Myeloid Leukemia and Leukostasis

By  

Acta Haematologica, Vol. 130, Iss. 2, 2013-03 ,pp. : 95-97

Karger

Access to resources Recommend Favorite

Health care utilization and end‐of‐life care for older patients with acute myeloid leukemia

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2840-2848

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes for patients with acute myeloid leukemia: A single‐center experience from AIIMS, India

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 3, 2015-09 ,pp. : 242-252

John Wiley & Sons Inc

Access to resources Recommend Favorite